| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 03/26/2008 | CN101151020A Adjuvanting material |
| 03/26/2008 | CN101148476A Inflammation related disease target treatment fusion protein |
| 03/26/2008 | CN101147807A Substances for preventing and treating autoimmune diseases |
| 03/26/2008 | CN101147787A Red glossy ganoderma Chinese medicinal herb composition |
| 03/26/2008 | CN101147779A Composition containing nucleotide, its preparation method and its use |
| 03/26/2008 | CN101147756A Medicinal composition containing total alooerine and licorice total flavone |
| 03/26/2008 | CN101147752A Biologic active element and its preparation technology |
| 03/26/2008 | CN101147581A White Chinese sorghum nutritive powder and preparation method thereof |
| 03/26/2008 | CN101147532A Compound Chinese medicinal herb feeding attraction and immunizing booster |
| 03/26/2008 | CN100376579C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and use in treating |
| 03/26/2008 | CN100376573C 1,3-dihydroimidazole fused-ring compound |
| 03/26/2008 | CN100376571C 6-substituted pyrido-pyrimidines |
| 03/26/2008 | CN100376554C N-substituted indol-3-glyoxylamid with antiasthmatic, antiallergic and immunosuppressive/immunomodulating effect |
| 03/26/2008 | CN100376530C Vitamin D analogues |
| 03/26/2008 | CN100376290C Antigenic peptides derived from telomerase |
| 03/26/2008 | CN100376288C Improvement of T cell mediated immunity |
| 03/26/2008 | CN100376264C Medicinal tea for treating apopsychia |
| 03/25/2008 | US7348431 Receptor or non-receptor; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor |
| 03/25/2008 | US7348419 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applications |
| 03/25/2008 | US7348410 Flea head, nerve cord, hindgut and malpighian tubule proteins |
| 03/25/2008 | US7348359 Retinoid X receptor modulators |
| 03/25/2008 | US7348341 Chemical compounds |
| 03/25/2008 | US7348336 Inhibitors of IkB kinase (I Kappa B Kinase); 1-acetyl-7-bromo- beta -carboline; antiinflammatory and anticarcinogenic agent; asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, infections, and cardiac infarct |
| 03/25/2008 | US7348327 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 03/25/2008 | US7348318 α-Amino-N-(diaminophosphinyl)lactam derivatives |
| 03/25/2008 | US7348177 Expression of HIV polypeptides and production of virus-like particles |
| 03/25/2008 | US7348148 Polynucleotide analog with polyether, polythioether, polyether sulfone, and/or and polyether sulfoxide linkages; antisense drug therapy |
| 03/25/2008 | US7348138 Diagnostic methods and kits for identifying individuals exposed to West Nile virus or other viruses including Flavivirus or Pestivirus |
| 03/25/2008 | US7348009 Recombinant allergen with reduced enzymatic activity |
| 03/25/2008 | US7347995 comprising an agent that targets an interleukin-15 receptor and a second agent that inhibits a costimulatory signal transmitted between a T cell and an antigen-presenting cell; treating autoimmune diseases, AIDS, vascular injuries or organ, tissue or cell transplant recipients |
| 03/25/2008 | CA2467265C Pharmaceutical composition for enhancing immunity, and extract of poria |
| 03/25/2008 | CA2432432C Use of (r)-ibuprofen methanesulfonamide and salts thereof in the treatment and prevention of rejection reactions of transplanted organs |
| 03/25/2008 | CA2419077C A method of treating a systemic disease |
| 03/25/2008 | CA2370446C Pharmaceutical compounds |
| 03/25/2008 | CA2319217C Pharmaceutical compositions |
| 03/25/2008 | CA2264822C Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses |
| 03/25/2008 | CA2217679C Peptides and therapeutic agent for autoimmune diseases containing the same |
| 03/25/2008 | CA2189984C P75 tnf receptor promoters |
| 03/25/2008 | CA2174707C Chromone derivatives as nk1 and substance p antagonists |
| 03/25/2008 | CA2164642C Novel compounds having a benzisoselen-azoline and -azine structure, method for preparing same and therapeutic uses thereof |
| 03/25/2008 | CA2115579C Ryegrass pollen allergen |
| 03/20/2008 | WO2008034008A2 Kinase inhibitors useful for the treatment of proliferative diseases |
| 03/20/2008 | WO2008033999A2 Kinase inhibitors useful for the treatment of proliferative diseases |
| 03/20/2008 | WO2008033932A2 Biarylthiazole carboxylic acid derivatives as protein tyrosine phosphatase-ib inhibitors |
| 03/20/2008 | WO2008033655A2 Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy |
| 03/20/2008 | WO2008033432A2 Immune modulation by chemically modified ribonucleosides and oligoribonucleotides |
| 03/20/2008 | WO2008033069A1 Selective chemokine modulation |
| 03/20/2008 | WO2008032847A1 External preparation for skin |
| 03/20/2008 | WO2008032764A1 Fused heterocyclic derivative |
| 03/20/2008 | WO2008032712A1 Monoclonal antibody and use thereof |
| 03/20/2008 | WO2008032665A1 Novel phenylacetic acid derivative |
| 03/20/2008 | WO2008032153A2 Calreticulin for its use as a medication for the treatment of cancer in a mammal |
| 03/20/2008 | WO2008032093A1 Cancer treatment |
| 03/20/2008 | WO2008031835A2 Method of treating autoimmune diseases using vegf-pathway inhibitors |
| 03/20/2008 | WO2008031438A2 Treatment of asthma, eczema and/or allergy using non-pathogenic organisms |
| 03/20/2008 | WO2008031437A2 Treatment of asthma, eczema and/or allergy using antibiotics |
| 03/20/2008 | WO2008031131A1 Method for the production of a mare milk preparation |
| 03/20/2008 | WO2008016692A3 Chemical compounds |
| 03/20/2008 | WO2007134350A3 Antibodies specific for bet v 1 and use thereof in the prevention and treatment of bet v 1-induced diseases |
| 03/20/2008 | WO2007066197A3 Immunomodulatory pharmaceutical composition containing a combination of three coumarinolignoids |
| 03/20/2008 | WO2001025398A3 Process for inducing functional tolerance to gene transfer products |
| 03/20/2008 | US20080071069 For delivering DNA/RNA into cells |
| 03/20/2008 | US20080071066 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 03/20/2008 | US20080071065 Fibroblast Growth Factor-Like Polypeptides |
| 03/20/2008 | US20080070989 Method of Evaluating Evenness of Suplatast Tosilate Crystal, Even Crystal, and Process for Producing the Same |
| 03/20/2008 | US20080070983 2-O- (Beta-D-Glucopyranosyl) ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it |
| 03/20/2008 | US20080070964 Opioid receptor active compounds |
| 03/20/2008 | US20080070957 p-(2-alkoxy-2-acylethyl)biphenyl compounds; 1-[4'-(2-ethoxy-3-morpholin-4-yl-3-oxopropyl)biphenyl-3-yl]-3-heptyl-1-methylurea; human or veterinary medicine: dermatology, cardiovascular diseases, immune diseases,; lipid metabolism diseases; Peroxisome Proliferator-Activated Receptor modulator |
| 03/20/2008 | US20080070950 Amorphous rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2- methylpropionic acid and its pharmaceutical compositions |
| 03/20/2008 | US20080070940 Side effect reduction of emesis; phosphodiesterase 4 (PDE4) inhibitor; 2-(3'-[3-[(cyclopropylamino)carbonyl)-4-oxo-1,8-naphthyridin-1(4H)-yl]-3-fluoro-1,1'-biphenyl-4-yl)cyclopropanecarboxylic acid, sodium salt; crystalline forms; allergies, autoimmune diseases, cancer, neurodegenerative disorders |
| 03/20/2008 | US20080070935 Isoquinoline, Quinazoline and Phthalazine Derivatives |
| 03/20/2008 | US20080070929 Thiazoline and oxazoline derivatives and their methods of use |
| 03/20/2008 | US20080070911 Ion channel modulating compounds and uses thereof |
| 03/20/2008 | US20080070901 Cholineterase inhibitors for treating inflammation |
| 03/20/2008 | US20080070893 Cancer, neurological disorders, autoimmune disorders; inhibitors of CK2, a serine/threonine kinase; based upon macrocyclic pyrazolo[1,5-a][1,3,5]triazine and pyrazolo[1,5-a]pyrimidine compounds |
| 03/20/2008 | US20080070880 Specific glucocorticosteroid compound having anti-inflammatory activity |
| 03/20/2008 | US20080070864 Modulating the activity of farnesoid X receptor (FXR) and/or orphan nuclear receptors; N-[3-(2,4-dimethylphenyl)-4-oxo-3,4-dihydroquinazolin-2-ylmethyl]benzenesulfonamide |
| 03/20/2008 | US20080070858 Administering a natriuretic hormone peptide (NHP), or a nucleic acid sequence encoding NHP; respiratory system disorders |
| 03/20/2008 | US20080070851 Method for the extraction of pharmaceutically active products from spermatophyte plants, products thus obtained and their use in the medical field, in particular as substances with immunomodulating activity |
| 03/20/2008 | US20080070843 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics |
| 03/20/2008 | US20080070259 Using presence or absence of mutation in metalloenzyme polynucleotides as diagnostic indicator of cardiovascular and neurodegenerative disorders |
| 03/20/2008 | US20080069867 Diagnostic and/or Remedy for Ovarian Cancer |
| 03/20/2008 | US20080069866 Immunotherapeutic methods and compositions |
| 03/20/2008 | US20080069859 Method for treating neovascularization and intravitreal implants |
| 03/20/2008 | US20080069842 Vaccines for Mycoplasma bovis and methods of use |
| 03/20/2008 | US20080069841 Pharmaceutical Compositions Containing Botulinum Neurotoxin A2 |
| 03/20/2008 | US20080069840 Immunotherapy ; antigen codes Dna vaccine; antitumor agents |
| 03/20/2008 | US20080069836 Method of using adenoviral vectors with increased immunogenicity in vivo |
| 03/20/2008 | US20080069825 Multiple CpG oligodeoxynucleotides and their use to induce an immune response |
| 03/20/2008 | US20080069815 Autoimmune diseases; rheumatic arthritis |
| 03/20/2008 | US20080069797 Rapamycin and il-10 for the treatment of immune diseases |
| 03/20/2008 | US20080069796 Low Dose Treatment with an Interleukin-11 Analog |
| 03/20/2008 | US20080069779 Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof |
| 03/20/2008 | US20080069777 Conformation Specific Antibodies |
| 03/20/2008 | US20080069775 Administering anti-idiotype antibody or antibody fragment comprising heavy chain variable region sequences and light chain variable region sequences conjugated to a soluble immunogenic carrier protein |
| 03/20/2008 | US20080069770 Monoclonal antibodies; used to modulate the immune system; no modulation of the totality of the T-cell population but only of the sub-assembly of T-cells expressing the beta sub-family specific to the T-cell receptors; used for organ transplant rejection |
| 03/20/2008 | DE69717831C5 Substituierte 2-(2,6-dioxopiperidin-3-yl)-phthalimide und -1-oxoisoindoline und verfahren zur reduzierung des tnf-alpha-spiegels Substituted 2- (2,6-dioxopiperidin-3-yl) -1-oxoisoindoline and -phthalimides and method for reducing the TNF-alpha levels |
| 03/20/2008 | CA2663259A1 Selective chemokine modulation |
| 03/20/2008 | CA2663234A1 Novel phenylacetic acid derivative |
| 03/19/2008 | EP1900816A2 GL50 molecules and uses therefor |